Table 4.
Comparison of pre-operative global parameters among four Groups with one-way ANOVA test
| Group CNK | Group CK | Group CMTK | Group CLTK | P value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| CNK and CK | CNK and CK | CNK and CLTK | CK and CMTK | CK and CLTK | CMTK and CLTK | |||||
| CA (°) | 4.2 ± 10.7 | −18.3 ± 6.7 | −18.4 ± 13.8 | −1.8 ± 10.4 | 0.00* | 0.00* | 0.03* | 1.0 | 0.13 | 0.17 |
| 0.00* | 0.00* | 0.00* | ||||||||
| CTA (°) | 6.5 ± 1 2.3 | −19.7 ± 6.9 | −33.8 ± 10.4 | −40.0 ± 11.2 | 0.00* | 0.00* | 0.00* | 0.01* | 0.00* | 0.61 |
| PI (°) | 52.7 ± 12.2 | 53.9 ± 15.3 | 53.5 ± 13.8 | 57.4 ± 12.3 | 1.00 | 0.94 | 0.87 | 0.97 | 0.91 | 0.99 |
| PT (°) | 11.1 ± 8.0 | 7.9 ± 9.0 | 13.8 ± 6.5 | 8.7 ± 5.8 | 0.36 | 0.66 | 0.92 | 0.13 | 0.99 | 0.62 |
| SS (°) | 41.7 ± 8.2 | 46.0 ± 10.4 | 39.7 ± 12.3 | 48.7 ± 8.6 | 0.48 | 1.00 | 0.39 | 0.59 | 0.89 | 0.42 |
| SSA (°) | 128.6 ± 7.7 | 134.2 ± 9.4 | 128.9 ± 9.9 | 136.9 ± 8.4 | 0.13 | 0.92 | 0.16 | 0.71 | 0.85 | 0.44 |
| Hip to C7/hip to sacrum | 11.0 (−10.4, 761.0) | −0.3 (−17.7, 6.4) | 0.4 (−0.6, 1.8) | 0.0 (−0.8, 1.9) | 0.50 | 0.58 | 0.71 | 0.97 | 0.99 | 0.99 |
| LL (°) | 55.0 ± 10.1 | 54.4 ± 12.8 | 46.7 ± 9.8 | 60.9 ± 11.7 | 0.98 | 0.13 | 0.64 | 0.40 | 0.56 | 0.10 |
| TK (°) | 36.0 ± 14.4 | 15.7 ± 13.9 | 3.3 ± 5.9 | 30.9 ± 6.9 | 0.00* | 0.00* | 0.85 | 0.02* | 0.12 | 0.00* |
In the post hoc Scheffe was selected in the one-way ANOVA test
*P < 0.05 was defined as statistically significant